Prestige Consumer Healthcare Inc. (PBH): Capital Expenditures
$11.18M
Year ended 2026-03-31
$14.04M
Trailing 12 months to 2026-06-30
+12.8%
3-year compound annual growth
-12.9%
5-year compound annual growth
+12.1%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $11.18M | +35.9% | 2026-05-14, From 2025-04-01 |
| 2025-03-31 | $8.22M | -13.9% | 2026-05-14, From 2024-04-01 |
| 2024-03-31 | $9.55M | +22.7% | 2026-05-14, From 2023-04-01 |
| 2023-03-31 | $7.78M | -19.3% | 2025-05-09, From 2022-04-01 |
| 2022-03-31 | $9.64M | -56.7% | 2024-05-15, From 2021-04-01 |
| 2021-03-31 | $22.24M | +52.8% | 2023-05-05, From 2020-04-01 |
| 2020-03-31 | $14.56M | +38.9% | 2022-05-06, From 2019-04-01 |
| 2019-03-31 | $10.48M | -16.4% | 2021-05-07, From 2018-04-01 |
| 2018-03-31 | $12.53M | +321.0% | 2020-05-08, From 2017-04-01 |
| 2017-03-31 | $2.98M | -16.6% | 2019-05-13, From 2016-04-01 |
| 2016-03-31 | $3.57M | -41.5% | 2018-05-10, From 2015-04-01 |
| 2015-03-31 | $6.10M | +120.7% | 2017-05-17, From 2014-04-01 |
| 2014-03-31 | $2.76M | -73.1% | 2016-05-17, From 2013-04-01 |
| 2013-03-31 | $10.27M | n/m | 2015-05-14, From 2012-04-01 |
| 2012-03-31 | $606.0K | -7.5% | 2014-05-19, From 2011-04-01 |
| 2011-03-31 | $655.0K | -2.7% | 2013-05-17, From 2010-04-01 |
| 2010-03-31 | $673.0K | n/a | 2012-05-18, From 2009-04-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $11.18M | +35.9% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $4.69M | +796.7% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $66.00M | +127.6% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $51.44M | +13.6% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $13.84M | -14.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $310.0K | -73.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.67M | -84.0% |
| Alkermes plc. (ALKS) | 2025-12-31 | $40.42M | +20.7% |
Compare PBH, ACAD, MDGL, INDV side by side · Screen every company in Pharmaceutical Preparations ↗